Status: current, Primitive. Date: 31-Jul 2009. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2820069013 | Golimumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 2820070014 | Golimumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Golimumab | Has disposition | Tumour necrosis factor alpha inhibitor | true | Inferred relationship | Some | ||
| Golimumab | Is a | Tumour necrosis factor alpha inhibitor | true | Inferred relationship | Some | ||
| Golimumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Golimumab | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Golimumab only product | Has active ingredient | True | Golimumab | Inferred relationship | Some | 1 |
| Golimumab 100 mg/mL solution for injection | Has BoSS | True | Golimumab | Inferred relationship | Some | 1 |
| Golimumab 100 mg/mL solution for injection | Has precise active ingredient | True | Golimumab | Inferred relationship | Some | 1 |
| Golimumab-containing product in parenteral dose form | Has active ingredient | True | Golimumab | Inferred relationship | Some | 1 |
| Golimumab only product in parenteral dose form | Has active ingredient | True | Golimumab | Inferred relationship | Some | 1 |
| Golimumab-containing product | Has active ingredient | True | Golimumab | Inferred relationship | Some | 1 |
| Golimumab 50mg injection solution 0.5ml prefilled syringe | Has active ingredient | False | Golimumab | Inferred relationship | Some | |
| Golimumab therapy | Direct substance | True | Golimumab | Inferred relationship | Some | 2 |
Reference Sets
Adverse reaction agent reference set
Substance foundation reference set
Australian dialect reference set
FHIR